235 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
EFFECT
GLMD
Galmed Pharmaceuticals Ltd
30 Nov 23
Notice of effectiveness
12:15am
POS AM
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Prospectus update (post-effective amendment)
4:48pm
6-K
rp4yp8c rvql5qh1w0
22 Nov 23
Current report (foreign)
4:05pm
6-K
vcykq0wm
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
POS AM
u732djkjtghuemwrlnqb
1 Nov 23
Prospectus update (post-effective amendment)
4:15pm
6-K
r0y4r0 5gntudwh5o
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
vwjbhsm4b
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
uiywbka82pbw
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
kat1hw
20 Sep 23
Current report (foreign)
4:30pm
6-K
1r8 2zk42r
13 Sep 23
Current report (foreign)
4:01pm
6-K
9zd0mmnvk 8uy50l72
9 Aug 23
Current report (foreign)
4:43pm
6-K
be8vg6cd9f
9 Aug 23
Current report (foreign)
4:30pm
6-K
t7ot pba7cwp4v
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
70buaemdy rautzrb
18 Jul 23
Current report (foreign)
9:25am
424B4
ykwfzq8f8ia
18 Jul 23
Prospectus supplement with pricing info
9:23am
EFFECT
r0i42q
17 Jul 23
Notice of effectiveness
12:15am
6-K
bfdkk 4lxnaz6hzm
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am